Psoriasis treatment study using skin imaging and quality of life
Part of Skin clinical trials.
This trial tests a new systemic therapy for severe plaque psoriasis and uses skin imaging (dermoscopy) to track improvements. It aims to see how well the treatment works and how it affects your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 6 years old.
- You have plaque psoriasis covering more than 10% of your body.
- Your doctor recommends starting a new medication like a pill or biologic injection.
- You are willing to stop any previous systemic treatments for 2-3 months before starting.
- You have at least one psoriasis plaque that can be photographed with a special skin camera.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests a new medication called HB0017 for moderate to severe plaque psoriasis. It aims to see if it is safe and effective in reducing skin symptoms and improving quality of life.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.